2022 American Transplant Congress » All Infections (Excluding Kidney & Viral Hepatitis) II

7:00pm-8:00pm

An Analysis of Serological Response and Infection Outcomes Following Oxford Astra-Zeneca (azd1222) and Pfizer-Biontech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Pancreas Transplant Patients

A. Asderakis¹, U. Khalid¹, G. Koimtzis¹, M. Ponsford², L. Szabó¹, L. Grant², S. Jolles², I. Humphreys³

7:00pm-8:00pm

Comparison of Outcomes of Covid-19 Between Fully Vaccinated and Unvaccinated Kidney Transplant Recipients and According to the Type of M-RNA Vaccine

F. Villanego¹, M. Crespo², V. Lopez³, S. Zarraga⁴, F. Oppenheimer⁵, L. Llinas², A. Andres⁶, C. Diaz⁷, M. Ruiz⁸, F. Moreso⁹, A. Rodriguez-Benot¹⁰, I. Beneyto¹¹, S. Cabello¹², C. Jimenez¹³, C. Canal¹⁴, M. Molina¹⁵, J. Pascual⁶, A. Mazuecos¹

7:00pm-8:00pm

Detection of Microbiota from Catheter Tip in Hemodialysis Patients During the Perioperative Period of Kidney Transplantation Based on Metagenomics: A Prospective Study

Z. Yan, Y. Wang, W. Zeng, R. Xia, W. Deng, J. Xu, Y. Miao

7:00pm-8:00pm

Differences in Strength and Longevity of SARS-CoV-2-Specific Adaptive Immunity Between Convalescent and Vaccinated SOT Patients and Immunocompetent Individuals

L. Donadeu¹, S. Gomez¹, A. Fava'², E. Crespo¹, F. Moreso³, M. Lopez³, L. Lladó⁴, J. González⁴, I. Campos³, M. Muñoz³, J. Quintero³, J. Esperalba³, O. Bestard³

7:00pm-8:00pm

Heterologous Vaccine Schedule Against Sars-CoV-2 with 2 Doses of Inactivated Virus and a Booster of mRNA BNT162b2 in Kidney Transplant Recipients

M. Seija¹, F. Rammauro², J. Santiago¹, N. Orihuela³, C. Zulberti³, D. Machado⁴, C. Recalde⁴, J. Noboa¹, R. Astesiano¹, F. Yandian¹, A. Guerisoli¹, A. Morra³, D. Cassinelli¹, A. Pippolo¹, B. De Aramburu¹, C. Coelho¹, P. González¹, R. Romero¹, R. Rodriguez-Teja⁴, G. Acuña⁴, V. Rabaza⁴, N. Perg⁴, R. Cordero⁴, S. Orihuela³, L. Curi³, E. Burgstaller⁴, O. Noboa¹, O. Pritsch², M. Nin¹, S. Bianchi⁵

7:00pm-8:00pm

Humoral and Cellular Immune Response to a Third Dose Of SARS-CoV-2 Vaccine in Kidney Transplant Recipients on Belatacept

J. Mitchell¹, J. Alejo¹, T. P. Chiang¹, J. N. Blankson¹, A. H. Karaba¹, B. Woldemeskel¹, C. Garliss¹, A. Chang¹, A. Abedon¹, R. K. Avery¹, A. Tobian¹, A. B. Massie¹, J. Garonzik-Wang², D. L. Segev¹, W. Werbel¹

7:00pm-8:00pm

Immunogenicity and Safety of SARS-CoV-2 Vaccines and Breakthrough Infections Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis

A. Villavicencio¹, Y. Ebisu², M. Raja³, A. P. Sanchez-Covarrubias¹, S. Anjan³, J. M. Reynolds¹, J. Simkins³, J. Camargo³, M. I. Morris³, L. Abbo⁴, G. Guerra⁵, Y. Natori⁶

7:00pm-8:00pm

Impact of Immunosuppression on T-cell Responses After mRNA-Based Sars-CoV-2 Vaccination

E. Wong¹, N. L. Bert², H. K. Sran¹, A. Lim¹, M. D'Costa¹, K. Akalya², S. Hang², A. Bertoletti², A. Vathsala¹

7:00pm-8:00pm

Increasing Proportion of High-Risk Cytomegalovirus (CMV) Donor Positive/recipient Negative (D+R-) Serostatus in Solid Organ Transplant Recipients (SOTRs)

H. Imlay¹, M. M. Wagener², N. Singh², A. P. Limaye³

7:00pm-8:00pm

One-Year Outcomes in Kidney Transplant Recipients with Acute Kidney Injury and COVID-19

P. Shrivastava¹, R. M. Hofmann², S. P. Norman³, D. Granger⁴, N. Khoury¹, R. Prashar¹, C. Crombez⁵, A. Patel¹, S. Nagai⁶, M. Lu⁷, M. Samaniego¹

7:00pm-8:00pm

Outcomes After Covid-19 Infection in Transplant Recipients

K. L. Freels¹, K. Saharia², J. Baddley², N. Costa³, S. Niederhaus⁴

7:00pm-8:00pm

Outcomes and Complications of Covid-19 in Pediatric Solid Organ Transplant Patients

L. Ott, P. Scalise, B. Kimball, A. G. Cuenca

7:00pm-8:00pm

Placement of COVID Positive Organs: An Early Analysis

A. M. Hawxby, R. Ketcham, J. P. Orlowski, R. Squires, C. Hostetler

7:00pm-8:00pm

Pre-Vaccine Antibodies Against Seasonal Betacoronaviruses Are Associated with Decreased Antibody Response to SARS-CoV-2 mRNA Vaccination in Solid Organ Transplant Recipients

A. Karaba¹, W. Zhou¹, T. Aytenfisu¹, T. S. Johnston¹, O. Akinde¹, Y. Eby¹, A. Abedon¹, J. Alejo¹, C. Qin¹, J. Garonzik-Wang², S. Klein¹, J. Bailey¹, A. Cox¹, J. Blankson¹, D. Segev¹, A. Tobian¹, W. Werbel¹

7:00pm-8:00pm

Preemptive  Therapy for Cytomegalovirus (CMV) Disease Prevention in High-Risk CMV Donor Seropositive Recipient Seronegative (D+/R-) Liver Transplant Recipients in a Real-World Setting 

K. M. Doss¹, C. Kling¹, M. R. Heldman¹, N. Singh², M. Wagener³, C. E. Fisher¹, A. Limaye¹

7:00pm-8:00pm

Prognostic Factors for Mortality of COVID-19 Infection in Kidney Transplant Recipients in Thailand: A Nationwide Study

A. Banjongjit¹, N. Larpparisuth², K. Phonphok³, P. Homkrailas⁴, O. Traitanon⁵, P. Inkong⁶, S. Wongpraphairot⁷, A. Lumpaopong⁶, T. Supaporn⁶, C. Pongskul⁸

7:00pm-8:00pm

Risk of Clostridioides Difficile Infection After Kidney Transplant

C. Thomas¹, B. Crowther², K. Schwarz², D. Chen¹, Y. Shandaliy¹, K. Johnson¹, P. Klem²

7:00pm-8:00pm

SARS-CoV-2 Antibody Response by mRNA Vaccine Platform in Incrementally Immunosuppressed Patients

J. Mitchell¹, C. Connolly¹, T. Chiang¹, J. Alejo¹, W. Werbel¹, D. Segev¹, A. Massie²

7:00pm-8:00pm

Sars-cov2 Antibody Kinetics and Durability Three and Six Months After Two-Doses of MRNA Vaccination in Liver Transplant Recipients

A. Chang¹, A. T. Strauss¹, T. P. Chiang¹, A. Jennifer¹, H. Nicole¹, L. Zeiser¹, B. Boyarsky¹, R. Avery¹, A. Tobian¹, M. Levan¹, D. Warren¹, A. Massie¹, J. Garonzik-Wang², D. Segev¹, W. Werbel¹

7:00pm-8:00pm

Three Month Antibody Durability and Kinetics in Sars-cov-2 Mrna Vaccinated Heart and Lung Transplant Recipients: Differences Above the Diaphragm

J. L. Alejo¹, J. Ruck¹, T. Chiang¹, A. Abedon¹, J. Kim¹, R. Avery¹, A. Tobian¹, M. Levan¹, D. Warren¹, A. Massie¹, W. Werbel¹, J. Garonzik-Wang², D. Segev¹